功能高分子材料教育部重点实验室

近期发表论文
当前位置: 首页 > 科技创新 > 近期发表论文 > 正文

史林启课题组 | JOURNAL OF CONTROLLED RELEASE

发布人:    发布时间:2023/01/06   浏览次数:

GOx-encapsulated iron-phenolic networks power catalytic cascade to eradicate bacterial biofilms

作者:

Piao, YZ (Piao, Yin-Zi) [1] , [2] ; Qi, Y (Qi, Yu) [2] ; Hu, XW (Hu, Xiao-Wen) [2] ; Wang, YR (Wang, Yaran) [2] ; Li, YF (Li, Yuanfeng) [3] ; Zhou, TL (Zhou, Tieli) [4] ; Shi, LQ (Shi, Linqi) [5] ; Liu, Y (Liu, Yong) [2] , [6] ; Zhou, CY (Zhou, Chaoyang) [1]

JOURNAL OF CONTROLLED RELEASE, 2022, 352:  1-14

DOI

10.1016/j.jconrel.2022.10.013

摘要

Bacterial biofilms, especially ones caused by multi-drug resistant strains, are increasingly posing a significant threat to human health. Inspired by nature, we report the fabrication of glucose oxidase-loaded iron-phenolic networks that can power the cascade reaction to generate free radicals to eradicate bacterial biofilms. A soft template, sodium deoxycholate, is employed to guarantee glucose oxidase activity during encapsulation, yielding the porous nanocomplexes after removing the template. The porous nature of nanocomplexes, characterized via transmission electron microscopy, N2 adsorption isotherms, and thermogravimetric analysis, facilitates the diffusion of substrates and products during the cascade reaction and protects glucose oxidase from protease attack. Our optimized nanocomplexes (Fe-GA/GOx) could efficiently kill drug-resistant ESKAPE pathogens, including the clinically isolated strains and eradicate their biofilms. In this regard, Fe-GA/GOx could induce over 90% of the biomass of Klebsiella pneumoniae and Staphylococcus aureus biofilms. In the murine peritonitis infection model induced by Staphylococcus aureus and pneumonia model induced by Klebsiella pneumoniae, our Fe-GA/GOx nanocomplexes could efficiently eradicate the bacteria (over 3-log reduction in colony-forming units) and alleviate the inflammatory response without notable side effects on normal tissues. Therefore, our strategy may provide an efficient alternative treatment to combat bacterial biofilms and address the emergence of drug resistance.